INTIMA BIOSCIENCE INC has a total of 24 patent applications. It decreased the IP activity by 76.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are ASKLEPIOS BIOPHARMACEUTICAL INC, CHENGDU INST OF BIOLOGICAL PRODUCTS CO LTD and ICON GENETICS GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Australia | 3 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | United States | 3 | |
#6 | Canada | 2 | |
#7 | United Kingdom | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Choudhry Modassir | 22 |
#2 | Henley Thomas | 21 |
#3 | Moriarity Branden | 13 |
#4 | Webber Beau | 13 |
#5 | Rhodes Eric | 12 |
#6 | Palmer Douglas C | 7 |
#7 | Restifo Nicholas P | 7 |
#8 | Rosenberg Steven A | 7 |
#9 | Viney Lydia | 6 |
#10 | Buerckstuemmer Tilmann | 5 |
Publication | Filing date | Title |
---|---|---|
WO2021067640A1 | Genetically modified plants and methods of making the same | |
WO2021067626A2 | Genetic engineering of fungi to modulate tryptamine expression | |
WO2021067645A1 | Genetically modified plants and methods of making the same | |
WO2020142236A1 | Modified adeno-associated viral vectors for use in genetic engineering | |
WO2020112860A1 | Methods of identifying immunomodulatory genes | |
CN111511375A | Adeno-associated virus vector for gene therapy | |
GB201906850D0 | Viral methods of T cell therapy | |
AU2017346885A1 | Tumor infiltrating lymphocytes and methods of therapy |